多发性硬化症中动作性震颤对异烟肼的反应及其用偏振光测角术进行的评估。
The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry.
作者信息
Francis D A, Grundy D, Heron J R
出版信息
J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):87-9. doi: 10.1136/jnnp.49.1.87.
Abstract
Isonicotinic acid hydrazide (isoniazid) was evaluated in five patients as a treatment for the control of severe cerebellar action tremor occurring in multiple sclerosis. Oral doses of isoniazid BPC were increased every 2 weeks from 300 mg to 1200 mg daily over an 8 week period. Four patients reported considerable symptomatic benefit at doses ranging from 600 mg to 900 mg daily. Polarised light goniometry demonstrated a two to three-fold reduction of tremor in these patients when standard methods of clinical assessment showed only marginal improvement.
摘要
对五名患者使用异烟肼评估其对多发性硬化症中出现的严重小脑性动作震颤的控制效果。在8周的时间内，口服英国药典标准的异烟肼剂量每2周从每日300毫克增加至1200毫克。四名患者报告称，在每日剂量为600毫克至900毫克时，症状有显著改善。偏振光测角法显示，这些患者的震颤减轻了两到三倍，而此时临床评估的标准方法仅显示有轻微改善。
相似文献
1
The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry.多发性硬化症中动作性震颤对异烟肼的反应及其用偏振光测角术进行的评估。
J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):87-9. doi: 10.1136/jnnp.49.1.87.
2
Treatment of action tremor in multiple sclerosis with isoniazid.
Neurology. 1982 Aug;32(8):912-3. doi: 10.1212/wnl.32.8.912.
3
A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.
J Neurol. 1987 Jan;234(1):36-9. doi: 10.1007/BF00314007.
4
Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis.
Neurology. 1985 Sep;35(9):1374-7. doi: 10.1212/wnl.35.9.1374.
5
Isoniazid for tremor in multiple sclerosis: a controlled trial.
Neurology. 1985 Dec;35(12):1772-5. doi: 10.1212/wnl.35.12.1772.
6
A double-blind trial of isoniazid for essential tremor and other action tremors.
Mov Disord. 1991;6(3):253-6. doi: 10.1002/mds.870060310.
7
Isoniazid and action tremor in multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1985 Mar;48(3):282-3. doi: 10.1136/jnnp.48.3.282.
8
Isoniazid and action tremor in multiple sclerosis.异烟肼与多发性硬化症中的动作性震颤
J Neurol Neurosurg Psychiatry. 1985 Sep;48(9):957. doi: 10.1136/jnnp.48.9.957.
9
Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury.
Arch Neurol. 1991 May;48(5):513-5. doi: 10.1001/archneur.1991.00530170077023.
10
Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report.
J Neurosurg. 2003 Oct;99(4):768-71. doi: 10.3171/jns.2003.99.4.0768.
引用本文的文献
1
Movement Disorders in Multiple Sclerosis: An Update.多发性硬化症中的运动障碍：最新进展。
Tremor Other Hyperkinet Mov (N Y). 2022 May 4;12:14. doi: 10.5334/tohm.671. eCollection 2022.
2
Cerebellar Contributions to Motor Impairments in People with Multiple Sclerosis.小脑对多发性硬化症患者运动障碍的影响。
Cerebellum. 2022 Dec;21(6):1052-1060. doi: 10.1007/s12311-021-01336-6. Epub 2021 Oct 17.
3
Tremor in Multiple Sclerosis-An Overview and Future Perspectives.多发性硬化症中的震颤——综述与未来展望
Brain Sci. 2020 Oct 12;10(10):722. doi: 10.3390/brainsci10100722.
4
Upper Limb Intention Tremor in Multiple Sclerosis: An Evidence-Based Review of Assessment and Treatment.多发性硬化症中的上肢意向性震颤：评估与治疗的循证综述
Int J MS Care. 2018 Sep-Oct;20(5):211-223. doi: 10.7224/1537-2073.2017-024.
5
Cerebellar Dysfunction in Multiple Sclerosis.多发性硬化症中的小脑功能障碍
Front Neurol. 2017 Jun 28;8:312. doi: 10.3389/fneur.2017.00312. eCollection 2017.
6
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.理解多发性硬化症中的震颤：患病率、病理解剖以及治疗的药物和手术方法。
Tremor Other Hyperkinet Mov (N Y). 2012;2. doi: 10.7916/D8Z60MR3. Epub 2012 Sep 14.
7
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.多发性硬化症的对症治疗：一种临床实践中多模式方法的综述。
Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.
8
Tremor in multiple sclerosis.多发性硬化症中的震颤
J Neurol. 2007 Feb;254(2):133-45. doi: 10.1007/s00415-006-0296-7. Epub 2007 Feb 21.
9
Multiple sclerosis therapy. A practical guide.多发性硬化症治疗。实用指南。
Drugs. 1995 Feb;49(2):200-12. doi: 10.2165/00003495-199549020-00005.
10
Neurological manifestations and toxicities of the antituberculosis drugs. A review.抗结核药物的神经学表现及毒性。综述
Med Toxicol. 1987 Jan-Feb;2(1):33-51. doi: 10.1007/BF03259859.
本文引用的文献
1
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.关于多发性硬化症残疾评估的进一步说明及量表修改
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
2
The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids.体液中异烟肼和对氨基水杨酸的定量测定。
Am Rev Tuberc. 1957 Nov;76(5):852-61. doi: 10.1164/artpd.1957.76.5.852.
3
Treatment of action tremor in multiple sclerosis with isoniazid.
Neurology. 1982 Aug;32(8):912-3. doi: 10.1212/wnl.32.8.912.
4
Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.各种神经和精神疾病中的脑脊液γ-氨基丁酸水平。
J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):257-60. doi: 10.1136/jnnp.45.3.257.
5
Failure of isoniazid therapy in Huntington disease.
Neurology. 1982 Oct;32(10):1189-91. doi: 10.1212/wnl.32.10.1189.
6
Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.亨廷顿舞蹈病。大脑中γ-氨基丁酸缺乏。
N Engl J Med. 1973 Feb 15;288(7):337-42. doi: 10.1056/NEJM197302152880703.
7
Isoniazid therapy of Huntington disease.
Neurology. 1979 Mar;29(3):370-5. doi: 10.1212/wnl.29.3.370.
8
Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.神经系统疾病中的脑脊液γ-氨基丁酸
Neurology. 1976 Aug;26(8):777-80. doi: 10.1212/wnl.26.8.777.
Zotero 插件